全文获取类型
收费全文 | 3366588篇 |
免费 | 272752篇 |
国内免费 | 6031篇 |
专业分类
耳鼻咽喉 | 48517篇 |
儿科学 | 107530篇 |
妇产科学 | 93029篇 |
基础医学 | 474911篇 |
口腔科学 | 99412篇 |
临床医学 | 306382篇 |
内科学 | 652386篇 |
皮肤病学 | 70337篇 |
神经病学 | 280608篇 |
特种医学 | 134293篇 |
外国民族医学 | 1247篇 |
外科学 | 506882篇 |
综合类 | 82906篇 |
现状与发展 | 4篇 |
一般理论 | 1426篇 |
预防医学 | 271849篇 |
眼科学 | 79727篇 |
药学 | 252250篇 |
6篇 | |
中国医学 | 6248篇 |
肿瘤学 | 175421篇 |
出版年
2018年 | 33601篇 |
2016年 | 28892篇 |
2015年 | 33032篇 |
2014年 | 46908篇 |
2013年 | 71738篇 |
2012年 | 96432篇 |
2011年 | 101995篇 |
2010年 | 60263篇 |
2009年 | 57527篇 |
2008年 | 97122篇 |
2007年 | 102869篇 |
2006年 | 104024篇 |
2005年 | 101165篇 |
2004年 | 98193篇 |
2003年 | 94518篇 |
2002年 | 93308篇 |
2001年 | 153519篇 |
2000年 | 158982篇 |
1999年 | 134981篇 |
1998年 | 39144篇 |
1997年 | 35489篇 |
1996年 | 34991篇 |
1995年 | 33936篇 |
1994年 | 31922篇 |
1993年 | 29858篇 |
1992年 | 109689篇 |
1991年 | 106063篇 |
1990年 | 102953篇 |
1989年 | 99465篇 |
1988年 | 92454篇 |
1987年 | 91215篇 |
1986年 | 86624篇 |
1985年 | 83054篇 |
1984年 | 63001篇 |
1983年 | 54074篇 |
1982年 | 32661篇 |
1981年 | 29177篇 |
1980年 | 27489篇 |
1979年 | 59838篇 |
1978年 | 42092篇 |
1977年 | 35521篇 |
1976年 | 33313篇 |
1975年 | 35267篇 |
1974年 | 43490篇 |
1973年 | 41540篇 |
1972年 | 38704篇 |
1971年 | 36030篇 |
1970年 | 33644篇 |
1969年 | 31418篇 |
1968年 | 28657篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
961.
962.
963.
964.
965.
966.
967.
C. M. Gordon E. Binello M. S. LeBoff M. E. Wohl C. J. Rosen A. A. Colin 《Osteoporosis international》2006,17(5):783-790
Introduction Patients with cystic fibrosis (CF) are known to be at risk for early osteoporosis, and the mechanisms that mediate bone loss
are still being delineated. The aim of the present investigation was to investigate if a correlation exists in these patients
between skeletal measurements by dual-energy x-ray absorptiometry (DXA) and two anabolic factors, dehydroepiandrosterone (DHEA)
and insulin-like growth factor I (IGF-I), and proresorptive factors such as the cytokines interleukin-1β, tumor necrosis factor α,
and interleukin-6.
Methods We studied 32 outpatients (18 females; mean age: 26.2 ± 7.9 years) at a tertiary care medical center. The subjects had venous
samples obtained, underwent anthropometric and bone mineral density (BMD) measurements, and completed a health survey. Serum
IGF-I concentrations were below the age-adjusted mean in 78% of the participants, and DHEA sulfate (DHEAS) concentrations
were low in 72%. Serum concentrations of all cytokines were on the low side of normal; nonetheless, there was a modest inverse
correlation between IL-1β and BMD at all sites.
Results In univariate analyses, IGF-I and DHEAS were significant correlates of BMD or bone mineral content. In final multivariate
models controlling for anthropometric and other variables of relevance to bone density, only IGF-I was identified as a significant
independent skeletal predictor. While alterations in DHEAS, IGF-I, and specific cytokines may contribute to skeletal deficits
in patients with CF, of these factors a low IGF-I concentration appears to be most strongly correlated with BMD.
Conclusions These findings may have therapeutic implications for enhancing bone density in these patients. 相似文献
968.
J. E. P. Rockell C. M. Skeaff S. M. Williams T. J. Green 《Osteoporosis international》2006,17(9):1382-1389
Introduction Vitamin D plays an important role in bone health. Our purpose was to measure serum 25-hydroxyvitamin D concentrations and their determinants in a national sample (n=2,946) of New Zealanders aged 15 years and over.Findings Mean (99% CI) serum 25-hydroxyvitamin D concentrations were 47 (45–50) nmol/l in women and 52 (49–55) nmol/l in men. Mean concentrations in New Zealand European and Others (NZEO, n=2,440), Mori (n=370), and Pacific (n=136) were 51 (49–53), 42 (38–46) and 37 (33–42) nmol/l, respectively. Three percent of New Zealanders had serum 25-hydroxyvitamin D concentrations indicative of deficiency (≤17.5 nmol/l); 48% and 84% were insufficient based on cutoffs of ≤50 and ≤80 nmol/l. Determinants of serum 25-hydroxyvitamin D concentrations in women were age, ethnicity, obesity, latitude and season; determinants in men were ethnicity and season. Serum 25-hydroxyvitamin D in women declined with age; mean concentration was 13 (8–18) nmol/l lower in women 65 years or older and 9 (5–13) nmol/l lower in women 45–64 years compared with women 15–18 years. Spring to summer differences in serum 25-hydroxyvitamin D were 31 (28–34) and 28 (25–31) nmol/l in women and men, respectively. Obese women had lower vitamin status than normal-weight women by 6 (3–10). Women living in the South Island had a mean serum 25-hydroxyvitamin D that was 6 (3–9) nmol/l lower than women living in the North Island. Ethnicity and season are the major determinants of serum 25-hydroxyvitamin D in New Zealanders.Conclusion The high prevalence of vitamin D insufficiency in New Zealanders, particularly in older women, may warrant strategies to improve vitamin D status. 相似文献
969.
Both vascular surgery and endovascular interventions traumatise the arterial wall, especially the endothelium. The vessel responds with neointimal hyperplasia and/or constrictive remodelling, and this is still the limiting factor in curative interventions. Stent placement prevents constrictive remodelling but is the main trigger for in-stent restenosis. Hyperproliferation of neointimal tissue is the main response to arterial thrombosis, local inflammation or medio-intimal injury such as occurs, for example, after balloon dilatation in the region of arterial anastomoses or of a thrombectomy (Fogarty-manoeuvre). At present, research on prevention of restenosis is focused on inhibiting neointimal hyperproliferation by using drug-eluting stents, and especially sirolimus- or paclitaxel-eluting stents. In addition, further experimental research work is in progress, with the aim of esablishing new treatment regimens and solving the problem of neointimal formation, thrombosis and constrictive remodelling. These include both local and systemic pharmacological therapy, brachy- and laser therapy, and many genetic treatment options, some of which are currently the subjects of experimental studies and early-stage clinical trials. Gene therapy seems like a promising way of preventing restenosis, but has not yet been tested in clinical trials. In the near future, selective, simultaneous, and perhaps even polyphasic regulation for gene silencing of two or more genes involved in the development of restenosis could improve the long-term patency rate. 相似文献
970.
Thomas J. Cahill Shehan Hettiaratchy Alex Clarke Peter E.M. Butler 《Transplantation reviews (Orlando, Fla.)》2006,20(2):76-81
Animal models have traditionally provided the basis for preliminary investigation of new techniques prior to trials taking place in human subjects. The timing of when to proceed with human trials is difficult, as the accuracy of preclinical models can only be determined with hindsight. This review outlines the progression from transplantation in animal models to man. Now that many transplant procedures are well established, it is possible to assess the predictive value and limitations of animal models. These results are of great importance in the current debate about composite tissue allotransplantation (CTA) and in particular facial transplantation. This progression of CTA from animal models to man is outlined and compared with early renal, cardiac, and liver transplants. There is some evidence to suggest that animal models may have been misleading in CTA and that this has effectively delayed the transition to humans. The role for animal models in facial transplantation, which is currently making the step to clinical trials, is discussed. 相似文献